Shanxi Ruifulai Pharmaceutical

Shanxi Ruifulai Pharmaceutical is a Chinese pharmaceutical company engaged in the research, development, manufacturing, and sale of finished drug products. The company is best known for its controlled-release transdermal patch capabilities and has operated a Beijing new drug R&D center in addition to manufacturing operations in Taiyuan, Shanxi. Historical company materials describe products including clonidine transdermal patches and ginkgo leaf tablets, with additional transdermal programs reported in clinical development. More recent corporate registry information indicates the legal entity remains active, but its current business scope appears to have shifted away from direct pharmaceutical manufacturing toward technology services, medical research, health consulting, warehousing, and Class I medical device-related activities. For diligence purposes, the company appears to be an exact legal-entity match to "RFL Pharmaceutical," but its present-day operating profile may differ from its historical pharma identity.